MASH Comorbidity Burden and Overall, Waiting List, and Post–Liver Transplant Mortality

Дата публикации: 05-08-2026 00:00:00

This cohort study examines the comorbidities and long-term outcomes associated with metabolic dysfunction–associated steatohepatitis (MASH) in patients on the liver transplant waiting list.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Serum C7 levels predict liver-related events in metabolic fatty liver disease, study finds	0	9.85	08-10-2026
2	Alcohol-Related Liver Disease: A Review	0	14.69	04-08-2026
3	Apolipoprotein L1 Gene Genotype and Kidney Outcomes After Living Kidney Donation	0	4.29	01-08-2026
4	Immune Checkpoint Inhibitor–Based Downstaging Therapy for Hepatocellular Carcinoma	0	7.13	01-10-2026
5	Cirrhosis can recur after liver transplant	0	8.75	22-09-2026
6	Mouse study identifies bile acid pathways that may reduce liver fat	0	9.19	17-09-2026
7	Imaging-based modalities compared for identifying at-risk MASH	0	18.34	16-10-2026
8	‘BMI does not tell the whole story in MASLD’; body roundness might	0	8.97	16-10-2026
9	Left Ventricular Dimension and Mortality in Patients With Heart Failure	0	3.96	05-08-2026
10	Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma	0	5.96	30-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.64. Источник: jamanetwork.com.